Adv Enzyme Tech - Advanced Enzyme Technologies Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Adv Enzyme Tech - Advanced Enzyme Technologies Share Price

368.957.56 (2.09%)

Closed
As On: 12 Jun, 2026, 03:45 PM IST
As On: 12 Jun, 2026, 03:54 PM IST

Sector: Agriculture/Hor...
Industry: Seeds/Tissue Cultu...

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	369.10
High	372.30
Low	362.50
Prev Close	361.40
Volume	69,150
VWAP(₹)	368.54

Key Metrics

PE Ratio(x)	24.48
EPS - TTM(₹)	15.07
MCap(₹ Cr.)	4,129.54
MCap Rank	3
PB Ratio(x)	2.47
Div Yield(%)	1.41
Face Value(₹)	2.00
52W High(₹)	419.00
52W Low(₹)	251.95
MCap/Sales	3.83
Beta(1 Month)	0.84
BV/Share(₹)	150.38

Adv Enzyme Tech share price insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 16.73%, which is highest in the last 3 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 16.51% outperformed its 3 year CAGR of 11.18%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 21.76% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Adv Enzyme Tech Share Price Update
Advanced Enzyme Technologies Ltd. share price moved up by 2.09% from its previous close of Rs 361.40. Advanced Enzyme Technologies Ltd. stock last traded price is 368.95
Share Price Value
Today/Current/Last 368.95370.15
Previous Day 361.40361.70

Found Insights useful?

Adv Enzyme Tech Share Price Returns

1 Day	2.09%
1 Month	-0.23%
3 Months	27.03%
1 Year	13.49%
3 Years	34.87%
5 Years	-10.84%

Adv Enzyme Tech Share Recommendations

Mean recosCurrent

BUY

1 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	-	-	-	-
Buy	1	1	1	1
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	1	1	1	1

Recent Recos

Target₹436
OrganizationHDFC Securities
BUY

Target₹405
OrganizationAxis Securities
BUY

Target₹300
OrganizationICICI Direct
HOLD

View all Stock Recommendations

News & Analysis

View all Adv Enzyme Tech Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	210.60	180.42	194.81	194.76	175.92
Total Income Growth (%)	16.73	-7.39	0.02	10.71	-0.49
Total Expenses	150.22	121.56	134.55	139.10	131.65
Total Expenses Growth (%)	23.58	-9.65	-3.27	5.66	7.18
EBIT	60.38	58.86	60.26	55.66	44.27
EBIT Growth (%)	2.58	-2.33	8.26	25.73	-17.96
Profit after Tax (PAT)	42.96	42.50	43.33	39.93	26.48
PAT Growth (%)	1.09	-1.91	8.50	50.78	-29.66
EBIT Margin (%)	28.67	32.62	30.93	28.58	25.16
Net Profit Margin (%)	20.40	23.56	22.24	20.50	15.05
Basic EPS (₹)	3.84	3.80	3.87	3.57	2.37

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	121.57	96.88	118.83	178.88	91.74
Total Income Growth (%)	25.49	-18.47	-33.57	94.99	-10.33
Total Expenses	92.67	79.02	89.16	97.43	76.15
Total Expenses Growth (%)	17.28	-11.38	-8.49	27.94	-6.79
EBIT	28.90	17.86	29.67	81.45	15.59
EBIT Growth (%)	61.82	-39.80	-63.57	422.58	-24.35
Profit after Tax (PAT)	22.30	13.25	22.28	73.98	11.05
PAT Growth (%)	68.29	-40.54	-69.88	569.27	-27.20
EBIT Margin (%)	23.77	18.44	24.97	45.53	16.99
Net Profit Margin (%)	18.34	13.67	18.75	41.36	12.05
Basic EPS (₹)	1.99	1.18	1.99	6.61	0.99

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	780.59	669.95	660.53	566.09	535.80
Total Revenue Growth (%)	16.51	1.43	16.68	5.65	4.92
Total Expenses	559.41	482.59	457.58	421.64	364.75
Total Expenses Growth (%)	15.92	5.47	8.52	15.60	21.45
Profit after Tax (PAT)	168.72	131.12	133.31	105.64	119.58
PAT Growth (%)	28.68	-1.64	26.19	-11.66	-18.21
Operating Profit Margin (%)	30.01	29.97	33.00	27.16	32.65
Net Profit Margin (%)	22.62	20.58	21.36	19.53	22.58
Basic EPS (₹)	15.08	11.72	11.92	9.45	10.70

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	516.15	412.90	424.28	321.34	281.88
Total Revenue Growth (%)	25.01	-2.68	32.04	14.00	-2.90
Total Expenses	354.62	292.37	271.34	247.06	209.81
Total Expenses Growth (%)	21.29	7.75	9.83	17.76	9.35
Profit after Tax (PAT)	131.81	102.42	108.12	55.53	54.51
PAT Growth (%)	28.69	-5.27	94.72	1.86	-23.24
Operating Profit Margin (%)	35.72	34.36	41.89	23.88	26.45
Net Profit Margin (%)	29.11	29.14	29.58	17.82	19.98
Basic EPS (₹)	11.78	9.16	9.67	4.97	4.88

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 16.73%, which is highest in the last 3 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 16.51% outperformed its 3 year CAGR of 11.18%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,838.76	1,621.35	1,535.46	1,421.85	1,267.61
Total Assets Growth (%)	13.41	5.59	7.99	12.17	9.97
Total Liabilities	155.64	152.68	164.38	137.68	127.22
Total Liabilities Growth (%)	1.94	-7.12	19.40	8.22	4.36
Total Equity	1,683.12	1,468.67	1,371.08	1,284.17	1,140.39
Total Equity Growth (%)	14.60	7.12	6.77	12.61	10.63
Current Ratio (x)	9.78	9.09	7.61	9.31	10.00
Total Debt to Equity (x)	0.01	0.02	0.02	0.01	0.01
Contingent Liabilities	0.00	21.69	20.36	14.12	9.49

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	803.64	688.63	632.93	575.80	529.62
Total Assets Growth (%)	16.70	8.80	9.92	8.72	8.25
Total Liabilities	94.01	59.29	52.46	50.47	49.27
Total Liabilities Growth (%)	58.56	13.02	3.94	2.44	-8.44
Total Equity	709.62	629.34	580.47	525.33	480.35
Total Equity Growth (%)	12.76	8.42	10.50	9.36	10.31
Current Ratio (x)	4.06	5.19	6.21	5.13	4.87
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	19.98	17.73	13.69	8.64

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	156.78	142.50	141.37	140.36	122.29
Net Cash used in Investing Activities	-74.13	-89.10	-64.65	-298.18	-24.91
Net Cash flow from Financing Activities	-70.37	-72.54	-59.24	-25.80	-27.38
Net Cash Flow	14.53	-19.53	17.33	-170.94	75.44
Closing Cash & Cash Equivalent	108.76	94.23	113.75	96.42	267.36
Closing Cash & Cash Equivalent Growth (%)	15.42	-17.17	17.97	-63.94	39.31
Total Debt/ CFO (x)	0.13	0.15	0.18	0.09	0.09

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	88.73	63.48	55.81	50.30	37.10
Net Cash used in Investing Activities	-34.19	-1.74	-6.88	-42.35	-14.24
Net Cash flow from Financing Activities	-58.25	-57.63	-56.88	-11.99	-10.87
Net Cash Flow	-3.71	4.11	-7.95	-4.05	11.99
Closing Cash & Cash Equivalent	1.89	5.60	1.50	9.45	13.50
Closing Cash & Cash Equivalent Growth (%)	-66.20	274.85	-84.18	-30.00	796.88
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 74.13 cr for investing activities which is an YoY decrease of 16.8%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	10.33	9.22	10.06	8.55	10.98
Return on Capital Employed (%)	12.92	12.52	14.40	10.92	14.31
Return on Assets (%)	9.17	8.08	8.68	7.42	9.43
Interest Coverage Ratio (x)	100.42	63.95	82.35	75.13	115.72
Asset Turnover Ratio (x)	0.43	0.40	0.42	0.34	0.32
Price to Earnings (x)	16.95	23.81	29.15	24.57	26.39
Price to Book (x)	1.75	2.20	2.93	2.10	2.90
EV/EBITDA (x)	10.66	13.55	15.82	13.91	14.16
EBITDA Margin (%)	35.38	35.71	38.64	33.64	39.26

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	18.57	16.27	18.62	10.56	11.34
Return on Capital Employed (%)	22.28	18.75	25.82	13.80	14.62
Return on Assets (%)	16.40	14.87	17.08	9.64	10.29
Interest Coverage Ratio (x)	839.72	560.04	1,044.55	627.38	860.29
Asset Turnover Ratio (x)	0.61	0.53	0.60	0.56	0.54
Price to Earnings (x)	21.69	30.49	35.97	46.73	58.14
Price to Book (x)	4.03	4.96	6.69	4.93	6.57
EV/EBITDA (x)	16.43	23.56	23.58	30.29	38.37
EBITDA Margin (%)	38.39	37.61	44.87	27.18	29.95

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
37%
Positive Movement
since 1st Jan 2005
on basis
62%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Adv Enzyme Tech	24.48	2.45	10.33	12.92	9.17	11.18	30.01	23.27	15.08	9.78	0.01	0.13
Kaveri Seed Co.	15.28	2.58	16.83	17.00	10.72	8.08	21.94	21.21	56.94	2.14	0.00	0.00
Bombay Super Hybrid	36.90	7.51	20.34	26.07	10.49	14.54	10.12	7.74	2.54	2.02	0.83	-6.85
Nath Bio-Genes	7.60	0.46	6.11	8.00	3.79	14.32	12.64	9.35	20.98	1.97	0.20	-11.02
Indo Us Bio-Tech	13.63	1.93	14.18	17.27	9.85	21.16	14.63	11.88	6.54	3.05	0.40	-2.30
Add More

Annual Ratios (%)

Choose from Peers

Shreeoswal Seeds
Agri-Tech (India)

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 4,84,20,535 43.26 % 0.21
Pledge 0 0.00 % 0.00
FII 2,85,32,094 25.50 % -0.35
DII 60,54,126 5.41 % -0.09
MF 21,62,016 1.93 % -0.23
Others 2,89,20,045 25.83 % 0.23
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 43.26 43.04 43.07 43.08
Pledge 0.00 0.00 0.00 0.00
FII 25.50 25.85 25.41 23.45
DII 5.41 5.51 6.41 8.45
Mutual Funds 1.93 2.16 3.24 5.46
Others 25.83 25.59 25.11 25.01

Mutual Funds Ownership

MF Ownership as on 30 April 2026

UTI MNC Direct-G
Equity: Thematic-MNC
- 36.09
  Amount Invested (in Cr.)
- 1.36%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru ESG Exclusionary Strategy Direct-G
Equity: Thematic-ESG
- 30.32
  Amount Invested (in Cr.)
- 2.24468552%
  % of AUM
- 0.00
  % Change (MoM basis)
Motilal Oswal Nifty Microcap 250 Index Direct-G
Equity: Small Cap
- 4.84
  Amount Invested (in Cr.)
- 0.21%
  % of AUM
- -2.23
  % Change (MoM basis)

View all Mutual Fund Schemes

Adv Enzyme Tech Top Searches

Corporate Actions

Recent
Final
67%
May 11, 2026
Board Meeting
Audited Results & Dividend
May 04, 2026
Board Meeting
Quarterly Results
Jan 23, 2026

Announced on	Meeting on
May 04, 2026	May 09, 2026
Audited Results & Dividend
Jan 23, 2026	Jan 31, 2026
Quarterly Results
Nov 04, 2025	Nov 12, 2025
Quarterly Results
Jul 25, 2025	Aug 02, 2025
Quarterly Results
May 06, 2025	May 13, 2025
Audited Results, Interim & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 06, 2025 Jul 23, 2025 60%
May 07, 2025 May 16, 2025 200%
May 06, 2025 May 16, 2025 0%
May 11, 2024 May 17, 2024 200%
May 11, 2026 - 67%
Bonus
No Data Available
Splits
Announced on Ex-Date
Feb 14, 2017 May 25, 2017
Split: Old FV10.0| New FV:2.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Jul 03, 2025 Jul 30, 2025
-
Jul 15, 2024 Jul 25, 2024
-
May 13, 2023 Aug 12, 2023
-
Aug 10, 2021 Sep 08, 2021
-
Jun 10, 2020 Jul 15, 2020
Book closure from Jul 11, 2020 to Jul 15, 2020

About Adv Enzyme Tech

Advanced Enzyme Technologies Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 4,129.54 Crore) operating in Agriculture/Horticulture/Livestock sector.

Advanced Enzyme Technologies Ltd. key Products/Revenue Segments include Enzymes and Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 210.59 Crore, up 16.73 % from last quarter Total Income of Rs 180.42 Crore and up 19.71 % from last year same quarter Total Income of Rs 175.92 Crore. Company has reported net profit after tax of Rs 45.25 Crore in latest quarter.

The company’s top management includes Mr.Vasant Rathi, Mr.Mukund Kabra, Ms.Rasika Rathi, Dr.Sunny Sharma, Mr.Nitin Desmukh, Mr.Pramod Kasat, Ms.Rajshree Patel, Mrs.Vandana Tilak, Mr.Vinodkumar Jajoo, Mr.Beni Rauka, Mr.Harshad Doshi, Mr.Sanjay Basantani. Company has BSR & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 11.19 Crore shares outstanding.

Adv Enzyme Tech Share Price Today is Rs. 368.95. On previous day, the Adv Enzyme Tech Share Price (NSE) closed at Rs. 371.3, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 43.26% of the stake in Adv Enzyme Tech shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Adv Enzyme Tech stocks was 25.5% as compared to 25.85% in Dec 2025 with decrease of 0.35%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 5.41% as compared to 5.51% in Dec 2025 with decrease of 0.1%. Out of the total DII holdings in Adv Enzyme Tech shares 1.93% was held by mutual funds. The rest including public held is 25.83%. Adv Enzyme Tech stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Adv Enzyme Tech Dividend: Ever since 1989, Adv Enzyme Tech dividends has been paid out around 15 times. As on 12 Jun, 2026, 03:45 PM IST, The overall dividend yield for Adv Enzyme Tech stands at 1.44%. The last dividend paid was on July 23, 2025 (Rs. 1.2). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 15.07.

Adv Enzyme Tech Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 210.59 Cr. of sales and 16.73% of quarterly net profit, there have been multiple ups and downs in the Adv Enzyme Tech stock prices in the past few weeks. For example, Adv Enzyme Tech stock price on 4th of June 2026 was around Rs. 376.5. Adv Enzyme Tech share price now stands at an average of Rs. 368.95. Judging by last week's performance, stock is in down trend.

Adv Enzyme Tech has a median target price of Rs. 370.0 in 12 months by 1 analysts. They have provided a high estimate of Rs. 370.0 and low estimate of Rs. 370.0 for Adv Enzyme Tech share.

Historical Prices and Performance:
Adv Enzyme Tech, incorporated in 1989 is a Small Cap company (with a market cap of Rs. 4045.03) operating in Agriculture/Horticulture/Livestock sector.
The Return of Equity (ROE) in last five financial years given by Adv Enzyme Tech stock was 10.33%, 9.22%, 10.06%, 8.55% and 10.98% respectively.
The Adv Enzyme Tech share gave a 3 year return of 31.73% as compared to Nifty 50 which gave a return of 24.77%.
Adv Enzyme Tech announced 60.0% final dividend on July 23, 2025.

Key Metrics:
PE Ratio of Adv Enzyme Tech is 23.97
Prices/Sales Ratio of Adv Enzyme Tech is 3.83
Price/Book Ratio of Adv Enzyme Tech is 2.4

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Adv Enzyme Tech, major competitors and peers include Kaveri Seed Co., Bombay Super Hybrid, Nath Bio-Genes and Indo Us Bio-Tech. As of Dec 2025, the dividend yield of Adv Enzyme Tech stands at 1.44% while Kaveri Seed Co., Bombay Super Hybrid, Nath Bio-Genes and Indo Us Bio-Tech stand at 0.57%, 0.0%, 1.21% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 23.97 and 2.4 respectively.

Leadership of Adv Enzyme Tech :
Sanjay Basantani is Company Secretary & Head - Legal
Beni Rauka is Chief Financial Officer
Dipak Roda is Senior VP - Marketing & Business Development
Harshad Doshi is CFO & COO
Martina Doering is Head - Business Development
Michael Puls is Head - Research & Development
Vasant Rathi is Non Executive Chairman
Mukund Kabra is Whole Time Director
Rasika Rathi is Non Executive Director
Sunny Sharma is Non Executive Director
Pramod Kasat is Independent Director
Vandana Tilak is Independent Director
Rajshree Patel is Independent Director
Nitin Desmukh is Independent Director
Vinodkumar Jajoo is Independent Director

Show More

Industry

Seeds/Tissue Culture/Bio Technology

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, Nifty Smallcap 500

Address

A - Wing, Sun Magnetica,5th Floor, LIC Service Road,Louiswadi,Thane, Maharashtra - 400604

Contact

info@advancedenzymes.com

http://www.advancedenzymes.com

Executive Leadership

VR

Vasant Rathi

Non Executive Chairman

MK

Mukund Kabra

Whole Time Director

RR

Rasika Rathi

Non Executive Director

SS

Sunny Sharma

Non Executive Director

Show More

Auditors

MSKA & Associates

BSR & Co. LLP

FAQs about Adv Enzyme Tech share

1. What's Adv Enzyme Tech share price today and what are Adv Enzyme Tech share returns ?
Adv Enzyme Tech share price is Rs 368.95 as on 12 Jun, 2026, 03:45 PM IST. Adv Enzyme Tech share price is up by 2.09% based on previous share price of Rs 371.3. Adv Enzyme Tech share price trend:
- Last 12 Months: Adv Enzyme Tech share price moved up 13.49%
- Last 3 Years: Adv Enzyme Tech Share price moved up by 34.87%
2. What are the returns for Adv Enzyme Tech share?
Return Performance of Adv Enzyme Tech Shares:
- 1 Week: Adv Enzyme Tech share price moved up by 0.52%
3. What's the market capitalization of Adv Enzyme Tech?
Adv Enzyme Tech share has a market capitalization of Rs 4,129.54 Cr. Within Agriculture/Horticulture/Livestock sector, it's market cap rank is 3.
4. What has been highest price of Adv Enzyme Tech share in last 52 weeks?
In last 52 weeks Adv Enzyme Tech share had a high price of Rs 419.00 and low price of Rs 251.95
5. What is the PE & PB ratio of Adv Enzyme Tech?
The PE ratio of Adv Enzyme Tech stands at 23.97, while the PB ratio is 2.4.

Top Gainers

As on 04:06 PM | 12 Jun 2026

84.57

14.09 (20.00%)

Authum Investment

530.15

70.20 (15.27%)

Tata Teleservices

46.44

4.29 (10.18%)

152.45

13.87 (10.01%)

Netweb Technologies

4,587.40

396.00 (9.45%)

Top Losers

As on 03:58 PM | 12 Jun 2026

1,375.70

-46.80 (-3.29%)

417.80

-11.56 (-2.70%)

246.20

-6.41 (-2.54%)

1,429.20

-35.90 (-2.46%)

OneSource Specialty

1,612.50

-38.91 (-2.36%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.